WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA announces safety changes in labeling for some cholesterol-lowering drugs 28 February 2012
FDA acts to bolster supply of critically needed cancer drugs 22 February 2012
FDA approves first generic version of cholesterol-lowering drug Lipitor 01 December 2011
Drug not Shown to be Safe and Effective in Breast Cancer Patients 21 November 2011
FDA begins process to remove breast cancer indication from Avastin label 16 December 2010
FDA warns consumers not to use Vigor-25 21 November 2010
FDA: Include warnings on risk for class of prostate cancer drugs 25 October 2010
FDA: Possible increased risk of thigh bone fracture with bisphosphonates 14 October 2010
FDA issues final rule on safety information during clinical trials 29 September 2010
Forest Pharmaceuticals agrees to guilty plea for violating FDA laws 16 September 2010
FDA Proposes Withdrawal of Low Blood Pressure Drug 17 August 2010
FDA to Communicate Safety Monitoring Activities to Consumers and Health Care Professionals 16 June 2010
FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli 27 May 2010
FDA Announces Collaboration with Drugs.com 27 May 2010
'Bad Ad Program' to Help Health Care Providers Detect, Report Misleading Drug Ads 14 May 2010
FDA Requests $4.03 Billion to Promote and Protect Public Health 03 February 2010
FDA Commissioner Addresses Nation's Healthcare Professionals on H1N1 Vaccine 12 November 2009
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 19 October 2009
FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR 07 October 2009
FDA: Cancer Warnings Required for TNF Blockers 04 August 2009
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End
Tahmeena

Business & Industry

  • Pfizer reports record full-year 2022 results
  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries

Research & Development

  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. FDA
  4. FDA launches app for health care professionals

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.